This report describes neurodevelopmental disorder, PRPF19-related, an autosomal dominant intellectual developmental disorder that has been associated with de novo missense mutations. The human gene implicated is PRPF19, which encodes pre-mRNA processing factor 19, a component of the Prp19 complex and U2-type catalytic step 2 spliceosome, which is involved in pre-mRNA splicing. There is one high-scoring fly ortholog, Dmel\Prp19, for which multiple genetic reagents, including classical alleles, RNAi-targeting constructs, and alleles caused by insertional mutagenesis, have been generated.
Multiple UAS constructs of the human Hsap\PRPF19 gene, including wild-type Hsap\PRPF19 and genes carrying mutational lesions, have been introduced into flies. See the 'Disease-Implicated Variants' table below. Partial heterologous rescue (functional complementation) has been demonstrated for the lethality and mushroom body phenotypes observed for pan-neuronal knockdown of Dmel\Prp19.
Pan-neuronal RNAi-mediated knockdown of Dmel\Prp19 is lethal prior to eclosion, and results in a generalized reduction in brain cell proliferation, with structural morphology defects of the larval mushroom body. Affected larvae exhibit hypoactivity in crawling behavior. Overexpression of wild-type or missense variant Hsap\PRPF19, but not a variant resulting in a truncated protein, fully rescue the survival rate and partially rescue mushroom body defects. Female adults in which pan-neuronal knockdown of Dmel\Prp19 was rescued with Hsap\PRPF19 missense variants exhibit changes in social space behavior, clustering closer to neighboring flies than do wild-type flies, which disperse throughout available space (FBrf0258439).
[updated Mar. 2024 by FlyBase; FBrf0222196]
A cohort of 6 unrelated individuals exhibit a neurodevelopmental phenotype associated with PRPF19 de novo missense variants, with core features of global developmental, speech, and motor delays, mild-to-severe ID, hypotonia, and autistic features. These core features are shared with disorders resulting from missense mutations in other genes involved in pre-mRNA splicing, including U2AF2 and RBFOX1 (Li, et al., 2024 pubmed:37962958; FBrf0258439).
Newly identified mutations in PRPF19 are mostly de novo missense variants (Li, et al., 2024 pubmed:37962958; FBrf0258439).
PRPF19 enables identical protein binding activity and ubiquitin-ubiquitin ligase activity. Involved in several processes, including DNA damage checkpoint signaling; cellular protein metabolic process; and mRNA splicing, via spliceosome. Acts upstream of or within protein polyubiquitination. Located in cytoplasm; nuclear speck; and site of double-strand break. Part of Prp19 complex and U2-type catalytic step 2 spliceosome. Colocalizes with DNA replication factor A complex. [provided by Alliance of Genome Resources, Apr 2022]
One to one (1 human to 1 Drosophila); PRPF19 has one high-scoring Drosophila ortholog, Prp19.
High-scoring ortholog of human PRPF19.